相关实验视频
Updated: Feb 19, 2026
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.8K
多组件干预措施减缓慢性病进展的有效性 G3-G4 阶段:系统性审查和元分析
Chenxinan Ma1, Lei Wu2, Yaxi Li3
1Program in Health Services Research & Population Health, Duke-NUS Medical School, Singapore, Singapore, 169857.
Clinical journal of the American Society of Nephrology : CJASN
|February 17, 2026
概括
多组分干预 (MCI) 显示出在G3-G4阶段减缓慢性病 (CKD) 进展并改善血糖控制的潜力. 然而,证据确定性低至中等,需要进一步进行高质量的研究.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 公共卫生 公共卫生
- 基于证据的医学基于证据的医学.
背景情况:
- 慢性病 (CKD) G3-G4阶段的管理通常涉及多组分干预 (MCI).
- 缺乏对MCI有效延缓CKD进展的集体证据的系统评估.
研究的目的:
- 系统地审查和对MCI在延缓CKD进展方面的有效性进行元分析.
- 评估MCI对CKD G3-G4.4阶段患者健康结果的影响.
主要方法:
- 在主要数据库 (PubMed,Embase,CENTRAL,Web of Science,CINAHL) 进行系统的文献搜索,截至2025年7月30日.
- 包括MCI的随机对照试验 (RCT) (持续时间≥6个月) 在患有CKD G3-G4.4的患者中.
- 随机效应的元分析,以评估MCI对估计的淋巴细胞过率 (eGFR) 和二次结果的影响.
主要成果:
- 分析了19个涉及36296名患者的RCT.
- 经过MCI检测,eGFR (MD=1.18) 和eGFR斜率 (MD=0.61) 略有改善,HbA1c也略有降低 (MD=-0.26).
- 对于白蛋白尿,血压或不良事件没有发现显著的影响.
结论:
- MCI可能在延缓CKD进展和改善CKD G3-G4患者的血糖控制方面发挥作用.
- 对关键结果的证据确定性低到中等,表明临床相关性适度.
- 需要高质量的研究来确认MCI的有效性,成本效益和可扩展性.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
494
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
494
01:18Chronic Kidney Disease IV: Nursing Management
422
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
422
01:24Chronic Kidney Disease II: Clinical Manifestations
730
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
730
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
248
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
248
01:25Chronic Kidney Disease I: Introduction
798
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
798
01:20Acute Kidney Injury V: Interprofessional Care
370
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
370